FDA.reportPublic FDA data

trastuzumab-strf 150 MG Injection

RxCUI
2700718
RxNorm name
trastuzumab-strf 150 MG Injection
Display name
trastuzumab-strf 150 MG Injection
Full name
trastuzumab-strf 150 MG Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:51

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761346Hercessitrastuzumab-strf351(k) BiosimilarRx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
285d2142-5bfa-401c-9246-7de21c4451aftrastuzumab-strf 150 MG InjectionPSN4These highlights do not include all the information needed to use HERCESSI safely and effectively. See full prescribing information for HERCESSI. HERCESSI TM (trastuzumab-strf) for injection, for intravenous use Initial U.S. Approval: 2024 HERCESSI (trastuzumab-strf) is biosimilar* to HERCEPTIN (trastuzumab).20250321
285d2142-5bfa-401c-9246-7de21c4451aftrastuzumab-strf 150 MG InjectionSCD4These highlights do not include all the information needed to use HERCESSI safely and effectively. See full prescribing information for HERCESSI. HERCESSI TM (trastuzumab-strf) for injection, for intravenous use Initial U.S. Approval: 2024 HERCESSI (trastuzumab-strf) is biosimilar* to HERCEPTIN (trastuzumab).20250321